Relapse prevention for people with HIV and alcohol use disorder
Alcohol Research Consortium in HIV: Relapse Prevention Arm
['FUNDING_P01'] · JOHNS HOPKINS UNIVERSITY · NIH-11180277
This project compares two short relapse-prevention programs—one computerized and one delivered by a counselor—against usual care to help people with HIV and alcohol use disorder keep reductions in drinking.
Quick facts
| Phase | ['FUNDING_P01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-11180277 on ClinicalTrials.gov |
What this research studies
If you have HIV and a history of alcohol use disorder, researchers will adapt a two-session relapse prevention program to fit HIV care settings. They will run a three-arm pilot where participants receive either the computerized program, a person-delivered version, or usual care to check feasibility and early signs of benefit. The sessions focus on building skills to prevent relapse, maintain treatment engagement, and reduce the frequency and intensity of drinking episodes. This is an early-stage NIH pilot meant to refine the interventions and gather initial data before larger trials.
Who could benefit from this research
Good fit: Ideal candidates are adults living with HIV who have an alcohol use disorder and have recently reduced or stopped drinking but remain at risk of relapse.
Not a fit: People without HIV, people without an alcohol use disorder, or those needing intensive inpatient detox or specialized addiction services are unlikely to benefit from this brief relapse-prevention program.
Why it matters
Potential benefit: If successful, the program could help people with HIV maintain drinking reductions, lower relapse rates, and improve engagement in HIV care.
How similar studies have performed: Related computer- and counselor-delivered alcohol interventions have helped people with HIV reduce drinking, but relapse-focused programs specifically for people with HIV are newer and less well tested.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HUTTON, HEIDI — JOHNS HOPKINS UNIVERSITY
- Study coordinator: HUTTON, HEIDI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus